Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
3.1 mil run rate. Revs rising every quarter, mostly on products.
More likely money laundering...
Caveat Emptor!!
..
.
Equipment write offs... medical equipment is not cheep. all in good time ! stem cells are the future. It is like everything new it take time and many many trials to get approval & fully accepted..
5.5 million loss on 1.3 million revenue??
Only people making money on this scam are the insiders paying themselves to be scammers.
Caveat Emptor!!
..
.
YoY revenue up 350%
Q4 over Q3 100% revenue growth
Baby steps
$1.5 million revenue for 2022
MC $250k
With all the volcanos and the earth quakes happening maybe they will shake this loose !
MSSV is still a scam run by a scammer.
Caveat Emptor
..
.
Now this needs the annual filed on time. It was late last year. Risky play of course, but if they keep filing and stay current, there's a lot of room to move up on any good news
https://www.otcmarkets.com/stock/MSSV/disclosure
MSSV $$$
$199,103 Market Cap - https://www.otcmarkets.com/stock/MSSV/security
Added some more yesterday
MSSV $$$
Maybe to a camel. And this isn't the desert.
Caveat Emptor
..
.
In the desert camel spit is worth a lot !
There's nothing here worth a bucket of camel spit.
Thanks for the answer. I was running the numbers and noticed that we were not charged ten dollars each on the TA fees for record holders for the LAHO buy back.
I gave my accountant all the transactions, had to figure out my own cost basis, thank god I’m pedantic about even share lots, and didn’t have a ton of different buys(only about 10).
I told him the situation, he told me, they are probably just risking a fine, but wasn’t sure why they’d do it, since it would be pretty easy to complete tge 1099s
Has anyone gotten their LAHO IRS 1099 yet?
Great. But I think one will need to see some actual volume for that to be possible. These consecutive days of no one buying the scam are not going to help in that lofty goal.
bullllllllllllllllllsheeeeeeeet!
In my instance, because I know this fraud from the days of James "Jimmy" Po Ho Cheung onwards.
https://vancouversun.com/news/staff-blogs/murder-victim-was-once-charged-with-laundering-drug-money
https://www.cbc.ca/news/canada/british-columbia/vancouver-shooting-victim-involved-in-online-gambling-1.663701
777 Sports was the original name of this perpetual scam.
After the murder of Cheung, Ken Chua and Alexander "Sandy" Anderson assumed control of the ticker and changed it to Oriens Hotel and Management. OTHM
Chua and Anderson were subsequently banned from the markets in Canada , and the Oriens scam partner, Pat Hundley was arrested for fraud in Costa Rica. OTHM was hyping a deal with Hundley where they merged with DayStar Properties.
https://www.wzzm13.com/article/news/investigations/13-on-your-side/watchdog/former-west-michigan-man-facing-fraud-charges-in-costa-rica/69-271532571
After Hundley was rolled up, and Chua and Anderson banned from the markets Melvin Pereira, Hundley's right hand man, assumed control of the fraud.
And changed the ticker to PNOW, which was supposedly in the online hotel and motel booking business with their website Oveedia.
Except that was an eternal infinity loop when one tried to book anything, anywhere. Although they would allow people to enter their credit/debit card numbers....
So yeah, some of us know what is really going on here.
How come all these “opinions” have been accurate?
Where's the millions and millions in revs???
Cavet Emptor
..
.
And just more interesting opinions...
It was just another in the long line of scams here.
So the ditched Numismatics?! SuWeet!!!
I love the Mexico City, and especially the Cancun story, they are solid moves IMHO. Destination Medical is a huge booming market.
Well with the promo starting Once again it will be interesting for sure.
Years of pumping that this is a big deal company…. Remember hearing all that nonsense. Meanwhile they are opening a clinic in Mexico. Lol
Trying? Plenty to be had.
Wow, 5 bucks would be amazing! I'm ready for a buck, or a buck fifty and BOOM...
Well, I view this as the "Buy Low" time period. I'm patient, and made bank with LAHO and even more here then. Trying to buy more now...
I tripled my money on LAHO... I took my original investment and bought this... I am hoping for 5 bucks on this one... I can wait.
Huh? There has been limited volume for a long time. Not many chances to make money.
Especially with their balance sheet? Yikes
I read comments like these and I just wonder... I'm making lots of money here with this gem. Buy low, sell hi. Doesn't seem so hard. To me, this does not equal a pump and dump, nor a scam or fraud. I mean, everything they sadi they would do, they've done, so really not sure what others are struggling with.
But maybe others have not had the successes I've had, so maybe why their might be doubts...
The last 10Q which was posted is through 06/30. Next 10Q due 11/15. Will be through September.
It’s been years of pumping from the company to get this crap.
https://www.otcmarkets.com/filing/html?id=16020466&guid=ovz-k6lorYfaEch
10Q coming. Let's see if its on time. Loving how much I'm making off this so called "fraud".
Really would like to see the financials... it has been a while !
MSSV's Global Stem Cells Group Announces Launch of New Stem Cells and Regenerative Medicine Clinic in CDMX
LAS VEGAS, NV, Oct. 28, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Meso Numismatics, Inc. (“Meso Numismatics” or the “Company”) (MSSV), a technology company specializing in Biotech and Numismatics, announces a new partnership that enhances Global Stem Cells Group’s goal of establishing its therapies and technology to meet market demand in populated areas of the world.
This collaboration with STEM LIFE clinic’s new facility and Dr. Vanessa Rodriguez Pares, currently one of the most prestigious aesthetic clinics in Mexico City, is expected to promote a high level of service in regenerative medicine throughout the country.
As part of this effort, the International Society for the Application of Stem Cells (ISSCA) has granted an affiliation and the use of their brand, products, therapies, and training on how to apply stem cell therapies to Dr. Vanessa Rodriguez Peers.
“This new partnership aims to expand the Global Stem Cells Group (GSCG) brand and create centers of excellence in cell therapy to meet the high demand in the Mexican market,” said Benito Novas, CEO of Global stem cells group “GSCG is rapidly expanding its global operations as it seeks to become a major player in the lucrative regenerative medicine industry. To achieve our expansion plans, our organization is partnering with healthcare providers specializing in regenerative medicine with at least five years of experience in the healthcare sector.”
We believe stem cell therapy is becoming an increasingly effective clinical solution for treating conditions that traditional or conventional medicine only offers within palliative care and pain management. Patients around the world are seeking a natural regenerative alternative without the potential risks and side effects sometimes associated with conventional pharmaceuticals.
The opening of this center, which will include the construction of an autologous tissue processing laboratory and an allogeneic tissue bank, is expected to help transition stem cell therapies and regenerative medicines from being an elective procedure to being accessible to patients throughout Mexico.
About Dr. Vanessa Rodriguez Pares
Dr. Vanessa Rodriguez Pares is a specialist in aesthetic medicine and surgery, with special attention to obesity and overweight in all ages. She is an expert in management of cosmetic surgery with a comprehensive approach to the patient, taking into account their safety and their physical, psychological, and emotional needs, as well as a specialist in ULTHERAPY treatment to perform facelift without surgery. In addition to extensive experience with cellular therapies and regenerative medicine since 2016, she specializes in anti-aging techniques, hair regeneration, and facial aesthetics with stem cell assisted lipotransfer, among other techniques.
About Global Stem Cells Group
Global Stem Cells Group, Inc. is the parent company of six wholly owned operating companies dedicated entirely to stem cell research, training, products, and solutions.
Founded in 2012, the company combines dedicated researchers, physician and patient educators, and solution providers with the shared goal of meeting the growing worldwide need for leading edge stem cell treatments and solutions. With a singular focus on this exciting new area of medical research, Global Stem Cells Group and its subsidiaries are uniquely positioned to become global leaders in cellular medicine Global Stem Cells Group’s corporate mission is to make the promise of stem cell medicine a reality for patients around the world. With each of GSCG’s six operating companies focused on a separate research-based mission, the result is a global network of state-of-the-art stem cell treatments.
Global Stem Cells Group is a publicly traded company operating under the symbol MSSV. https://finance.yahoo.com/quote/mssv/
To learn more about Global Stem Cells Group, Inc.’s companies visit our website
www.stemcellsgroup.com or call +1 305 560 5331
https://www.globenewswire.com/news-release/2022/10/28/2543720/0/en/MSSV-s-Global-Stem-Cells-Group-Announces-Launch-of-New-Stem-Cells-and-Regenerative-Medicine-Clinic-in-CDMX.html
MSSV $$$
Good opportunity to get out…
Thanks. Best of luck to you too.
LAS VEGAS, NV, Feb. 05, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire -- Meso Numismatics, Inc. (“Meso Numismatics” or the “Company”) (MSSV), a regenerative medicine company is pleased to announce that it will be undergoing a name change from Meso Numismatics Inc. to Regenerative Medical Technology Group Inc. to better reflect the company’s business. The Company will also change its authorized shares outstanding from the current 6.5 billion to 100 million shares. Please see the Information Statement on Schedule 14C filed by the Company on February 2, 2024, and other Company filings at www.sec.gov.
About Meso Numismatics: Meso Numismatics Corp is a regenerative medicine company offering diverse products and services through its wholly owned subsidiary Global Stem Cells Group. The Company currently has a network of 26 clinics in 21 countries that carry its banner and has its own clinic in Cancun and is currently building another one in Dubai. The Company distributes stem cells and other regenerative based cell lines, and equipment internationally and also specializes in education and training physicians in the area of regenerative medicine.
For more information on Global Stem Cells Group please visit: www.stemcellsgroup.com
Forward-Looking Statements
Some information in this document constitutes forward-looking statements or statements which may be deemed or construed to be forward-looking statements, such as the closing of the share exchange agreement. The words “plan”, "forecast", "anticipates", "estimate", "project", "intend", "expect", "should", "believe", and similar expressions are intended to identify forward-looking statements. These forward-looking statements involve, and are subject to known and unknown risks, uncertainties and other factors which could cause the Company's actual results, performance (financial or operating) or achievements to differ from the future results, performance (financial or operating) or achievements expressed or implied by such forward-looking statements. The risks, uncertainties and other factors are more fully discussed in the Company's filings with the U.S. Securities and Exchange Commission. All forward-looking statements attributable to Lans Holdings Inc., herein are expressly qualified in their entirety by the above-mentioned cautionary statement. Lans Holdings Inc. disclaims any obligation to update forward-looking statements contained in this estimate, except as may be required by law.
For further information, please contact:
Investor.relations@mssvinc.com
Telephone: (800) 956-3935
The Cancun clinic is currently active and is finalizing its full build out, which will double its footprint by the end of February. The clinic is also comprised of a lab where stem cell cultures can be produced. The Cancun clinic currently offers numerous procedures for multiple indications including: hormone replacement, autoimmune, neurodegenerative, osteoarthritis, cardiovascular, aesthetic/anti-aging, hair transplant, sports medicine, spinal cord injury, MS, and autism. The Company is in the process of building out a clinic in Dubai that will offer similar procedures to those in the Cancun location. The Dubai clinic is expected to be fully operational by the end of the second quarter of this year.
The Company plans to close on two additional locations for new clinics, one by the end of the third quarter and one by the end of the fourth quarter of this year. Both of these clinics are expected to be operational by the end of the second quarter of 2025.
The Company also has a collaboration with an Istanbul based clinic where the Company refers patients and receives patient referrals on various patient procedures.
The Company operates in the stem cell therapy market, which is expected to grow from $11.2 billion in 2022 to $31.4 billion by 2030 according to Precedence Research. The Company has also entered the exosome market, which is expected to grow from $250 million in 2022 to $3.2 billion by 2032 according to Global Market Insights.
The Company is actively collaborating with leading research institutions, universities, and industry experts to accelerate the development and commercialization of regenerative medical solutions. These partnerships create a collaborative ecosystem that fosters scientific excellence and ensures that the Company remains at the forefront of innovation, contributing to medical advancements and expanding its range of products. With a global vision, the Company is dedicated to making a positive impact on healthcare worldwide. The company is exploring opportunities to expand its reach and make its cutting-edge medical procedures accessible to patients across borders.
"We are thrilled to be at the forefront of regenerative medicine, bringing hope to patients and pushing the boundaries of what is possible in biotechnology. Our commitment to innovation and collaboration underscores our mission to make a lasting impact on the lives of individuals facing challenging medical conditions," said David Christensen, CEO and President of the Company.
The driving forces behind Global Stem Cells Group's strategy to increase revenue in 2024 involve a multifaceted approach within the rapidly expanding stem cell therapy market. As the wholly-owned subsidiary of the Company, Global Stem Cells Group specializes in cutting-edge stem cell research collaborations and physician training. The key components contributing to revenue growth include:
Certified Training Courses for Physicians - Offering specialized and certified training courses to physicians, ensuring they are equipped with the latest knowledge and skills in stem cell therapies. The Company is internationally recognized as an expert in the field of stem cells and regenerative medicine.
Manufacturing and Sales of the Latest Technology, Supplies, and Equipment - Engaging in the production and sale of state-of-the-art technology, supplies, and equipment related to stem cell applications, catering to the needs of medical professionals in the field.
Research and Development of Clinical Protocols - Investing in research and development collaborations to create advanced clinical protocols for stem cell applications, enhancing the efficacy and safety of treatments.
Regenerative Medical Clinics - Cancun, Dubai, and Istanbul, Provide standardized regenerative medical treatments. These treatments cover a spectrum of health issues, including musculoskeletal disorders, autoimmune diseases, aesthetics, and anti-aging.
Franchising Network of Regenerative Medical Practitioners - Establishing a network of franchised regenerative medical practitioners, potentially increasing the geographical reach and accessibility of stem cell treatments. Currently 26 clinics in 21 countries carry the Company's banner. This allows the Company to raise its global profile and branding and assist the company in bringing patients to its own clinics.
Turnkey Solutions for Stem Cell Processing Center Installation & Management - Offering comprehensive complete solutions for the installation and management of stem cell processing centers, providing a one-stop solution for practitioners entering the field.
By diversifying into these key areas Global Stem Cells Group aims to tap into various aspects of regenerative medicine, creating revenue streams through education, product sales, research, patient services, and strategic partnerships within the stem cell therapy market.
"We are excited to announce our significant growth across multiple channels, showcasing the strength and diversity of our business. The success in training, product sales, equipment sales, and patient procedures reflects our commitment to excellence in every facet of regenerative medicine," said Benito Novas, CEO and Founder of Global Stem Cells Group.
This press release should be read in conjunction with all of the Company's filings on www.sec.gov
About Meso Numismatics: Meso Numismatics, Inc. is a regenerative medicine company offering diverse products and services through its wholly owned subsidiary Global Stem Cells Group. The Company currently has a network of 26 clinics in 21 countries that carry its banner and has its own clinic in Cancun and is currently building another one in Dubai. The Company distributes stem cells and other regenerative based cell lines and equipment internationally and also specializes in educating and training physicians in the area of regenerative medicine.
For more information on Global Stem Cells Group please visit: www.stemcellsgroup.com
Forward Looking Statements
Some information in this document constitutes forward-looking statements or statements which may be deemed or construed to be forward-looking statements, such as the closing of the share exchange agreement. The words "plan", "forecast", "anticipates", "estimate", "project", "intend", "expect", "should", "believe", and similar expressions are intended to identify forward-looking statements. These forward-looking statements involve, and are subject to known and unknown risks, uncertainties and other factors which could cause the Company's actual results, performance (financial or operating) or achievements to differ from the future results, performance (financial or operating) or achievements expressed or implied by such forward-looking statements. The risks, uncertainties and other factors are more fully discussed in the Company's filings with the U.S. Securities and Exchange Commission. All forward-looking statements attributable to Lans Holdings Inc., herein are expressly qualified in their entirety by the above-mentioned cautionary statement. Lans Holdings Inc. disclaims any obligation to update forward-looking statements contained in this estimate, except as may be required by law.
For further information, please contact:
Investor.relations@mssvinc.com
Telephone: (800) 956-3935
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |